Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to... see more

TSXV:SBM - Post Discussion

Sirona Biochem Corp > New tech for skin care
View:
Comment by biorun on Oct 25, 2022 10:08am
Everyone has a product to improve beauty/skin etc It all boils down to hard objective results with clinical backing. The results, if impressed will drive the enterprise value as the compound is Novel, meaning there is nothing like it on the market. It is 100% Sirona invention. On that front I think the value of anti-aging will be correlated to the effectiveness to impact/rebuild the subdermal ...more  
Comment by fanculox on Oct 25, 2022 10:19am
bla bla bla, are there no hookers near you?
Comment by Turtle4 on Oct 25, 2022 10:37am
The management has decided that they would rather not have a high upfront in order to finance the study themselves. Only one company will see the results. So there will be no bidding war.    The potential is huge, but Sirona and its shareholders will not benefit too much from it.
Comment by biorun on Oct 25, 2022 11:38am
Again, this is full of holes.
Comment by Turtle4 on Oct 25, 2022 12:59pm
sironas revenue is full of holes
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse